Bellicum Pharmaceuticals, Inc.

BLCM · NASDAQ
Analyze with AI
9/30/2023
6/30/2023
3/31/2023
12/31/2022
Assets
Cash & Equivalents$5,909$7,410$15,402$21,837
Short-Term Investments$0$0$0$0
Receivables$15$0$8$0
Inventory$0$0$0$0
Other Curr. Assets$924$1,302$1,826$1,964
Total Curr. Assets$6,848$8,712$17,236$23,801
Property Plant & Equip (Net)$5$21$24$22
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$0
Total NC Assets$5$21$24$22
Other Assets$0$0$0$0
Total Assets$6,853$8,733$17,260$23,823
Liabilities
Payables$526$472$1,226$486
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$1,723$3,010$3,490$3,286
Total Curr. Liab.$2,249$3,482$4,716$3,772
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$31,618$27,091$22,564$18,036
Total NC Liab.$31,618$27,091$22,564$18,036
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$33,867$30,573$27,280$21,808
Equity
Pref Stock$31,618$27,091$22,564$0
Common Stock$98$96$91$87
Retained Earnings-$591,606-$590,843-$583,491-$575,425
AOCI-$354-$354-$354-$354
Other Equity$533,230$542,170$551,170$577,707
Total Equity-$27,014-$21,840-$10,020$2,015
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$6,853$8,733$17,260$23,823
Net Debt-$5,909-$7,410-$15,402-$21,837